Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pact
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
- Latest
- Trending
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
Investment company Investcorp plans to list a portfolio company in the Gulf region by 2024, with optimism for completion in ...
The winning momentum trade may be losing steam, according to technical analyst Jonathan Krinsky. The market could experience a turning ...
Citigroup raises price target for Spirit Airlines but maintains sell rating due to concerns of equity dilution and limited impact ...
The highly-touted ERC-404 tokens on Ethereum have experienced a 29% drop in market capitalization, raising doubts about their viability and ...
Chainlink's market value has surpassed Dogecoin following intense buying activity by a large-scale investor. The surge in price has propelled ...
Teri Hatcher reveals her struggles with dating apps and her decision to find love the old-fashioned way in a candid ...
The climactic battle between Dominaria and Phyrexia reaches its climax, with betrayals and sacrifices along the way. The heroes face ...
Finding New Adventures: My Late Introduction to Gaming. Read about how one man's exploration into the world of gaming changed ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.